Enanta Pharmaceuticals (ENTA) Change in Taxes (2014 - 2019)

Enanta Pharmaceuticals (ENTA) has 6 years of Change in Taxes data on file, last reported at -$5.9 million in Q1 2019.

• Quarterly Change in Taxes fell 20.11% year-over-year to -$5.9 million in Q1 2019, while the trailing twelve-month figure through Sep 2024 was -$5.9 million (changed N/A YoY) and the FY2025 annual result came in at $33.8 million, changed N/A from the prior year.
• Change in Taxes retreated to -$5.9 million in Q1 2019, from $4.5 million in the prior quarter.
• In the past five years, Change in Taxes ranged from a high of $4.5 million in Q4 2018 to a low of -$12.3 million in Q2 2015.
• A 5-year average of -$1.9 million and a median of -$1.2 million in 2016 frame the typical range for Change in Taxes.
• Annual changes were most pronounced in 2015 — Change in Taxes slumped 77.86% — and 2018, when it soared 366.11%.
• Tracing ENTA's Change in Taxes over 5 years: stood at $3.7 million in 2015, then plunged by 132.24% to -$1.2 million in 2016, then jumped by 179.52% to $959000.0 in 2017, then jumped by 366.11% to $4.5 million in 2018, then plunged by 231.05% to -$5.9 million in 2019.
• The last three Change in Taxes figures came in at -$5.9 million (Q1 2019), $4.5 million (Q4 2018), and $1.4 million (Q3 2018), per Business Quant data.